title: Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bonacini
authors.forename: Alan
authors.initials: A
authors.lastname: Kurz
authors.forename: Stephen
authors.initials: S
authors.lastname: Locarnini
authors.forename: Anna
authors.initials: A
authors.lastname: Ayres
authors.forename: Craig
authors.initials: C
authors.lastname: Gibbs
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D017809:Fatal Outcome; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D017093:Liver Failure / Q000821:virology*; D008297:Male; D008875:Middle Aged; D009154:Mutation
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine